Vitamin E and the treatment and prevention of diabetes: A case for a controlled clinical trial

Singapore Medical Journal

Volumn 43, Issue 9, 2002, Pages 479-484

  Halliwell, B ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Diabetes; Free radical; Lipid peroxidation; Oxidative damage; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; FREE RADICAL; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; RETINA BLOOD FLOW; REVIEW; RISK FACTOR; VASCULAR ENDOTHELIUM; ANIMAL; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; INCIDENCE; MALE; PHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGAPORE;

ANIMALS; ANTIOXIDANTS; CONTROLLED CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INCIDENCE; LIPID PEROXIDATION; MALE; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGAPORE; VITAMIN E;

EID: 0036708823     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Hughes K, Choo M, Kuperan P, Ong CN and Aw TC. Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: A population-based survey among Asians in Singapore. Atherosclerosis 1998; 136:25-31.
2. Halliwell B and Gutteridge JMC. Free Radicals in Biology and Medicine, Third Edn, 1999 Oxford University Press, UK.
3. Babior BM. Phagocytes and oxidative stress. Am J Med 2000; 109:33-44.
4. Parks E and Traber MG. Mechanisms of vitamin E regulation: Research over the past decade and focus on the future. Antioxid Redox Signal 2000; 2:405-12.
5. Parthasarathy S, Santanam N, Ramachandran S and Meilhac O. Potential role of oxidized lipids and lipoproteins in antioxidant defence. Free Radic Res 2000; 33:197-215.
6. Kappus H and Diplock AT. Tolerance and safety of vitamin E: A toxicological position report. Free Radic Biol Med 1992; 13:55-74.
7. Oranje WA and Wolffenbuttel BHR. Lipid peroxidation and atherosclerosis in type II diabetes. J Lab Clin Med 1999; 134:19-32.
8. Bonnefont-Rousselot D, Bastard JP, Jaudon MC and Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes & Metabolism 2000; 26:163-76.
9. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Constantini F, Capani F and Patrono C. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation 1999; 99:224-9.
10. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B and Betteridge DJ. Relationships Between Plasma Measures of Oxidative Stress and Metabolic Control in NIDDM 1997; 40:647-53.
11. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R and Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 1996; 90:255-60.
12. Devaraj S, Hirany SV, Burk RF and Jialal T. Divergence between LDL oxidative susceptibility and urinary F2-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem 2001; 47:1974-9.
13. Laight DW, Carrier MJ and Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 2000; 47:457-64.
14. Nishikawa T, Edelstein D, Du XL, Yamagishi S-I, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes H-P, Giardino I and Brownlee M. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-90.
15. Zanetti M, Zwacka RM, Engelhardt JF, Katusic ZS and O'Brien T. Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia. Arterioscler Thromb Vasc Biol 2001; 21:195-200.
16. Wautier M-P, Chappey O, Corda S, Stern DM, Schmidt AM and Wautier J-L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol 2001; 280: E685-E694.
17. Yang X, Borg LAH and Eriksson UJ. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 1997; E173-E180.
18. Greene DA, Sima AA, Stevens MJ, Feldman EL and Lattimer SA. Complications: Neuropathy, pathogenetic considerations. Diabetes Care 1992; 15:1902-25.
19. Hagay ZJ, Weiss Y, Zusman I, Peled-Kamar M, Reece EA, Eriksson UJ and Groner Y. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 1995; 173:1036-41.
20. Guha M, Bai W, Nadler JL and Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 2000; 275:17728-39.
21. Devaraj S and Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: The effect of alpha-tocopherol supplementation. Circulation 2000; 102:191-6.
22. Hofmann MA, Schiekofer S, Kanitz M, Klevesath MS, Joswig M, Lee V, Morcos M, Tritschler H, Ziegler R, Wahl P, Bierhaus A and Nawroth PP. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type I diabetes. Diabetes Care 21, 1310-6.
23. Chirico S, Smith C, Marchant C, Mitchinson MJ and Halliwell B. Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radic Res Commun 1993; 19:51-7.
24. Palombo C, Lubrano V and Sampietro T. Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia. Cardiovasc Res 1999; 44:474-6.
25. Walzem RL, Watkins S, Frankel EN, Hansen RJ and German JB. Older plasma lipoproteins are more susceptible to oxidation: A linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease. Proc Natl Acad Sci USA 1995; 92:7460-4.
26. Jain SK, McVie R, Jackson R, Levine SN and Lim G. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care 1999; 22:1171-5.
27. Sakata N, Uesugi N, Takebayashi S, Nagai R, Jono T, Horiuchi S, Takeya M, Itabe H, Takano T, Myint T and Taniguchi N. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Cardiovasc Res 2001; 49:466-75.
28. Guzel S, Seven A, Satman I and Burcak G. Comparison of oxidative stress indicators in plasma of recent-onset and long-term type I diabetic patients. J Toxicol Environ Health A 2000; 59:7-14.
29. Hartnett ME, Stratton RD, Browne RW, Rosner BA, Lanham RJ and Armstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 2000; 23:234-40.
30. Van der Jagt DJ, Harrison, JM, Ratliff, DM, Hunsaker, LA and Van der Jagt, DL. Oxidative stress indices in IDDM subjects with and without long-term diabetic complications. Clin. Biochem 2001; 34:265-70.
31. Chowienczyk PJ, Brett SE, Gopaul NK, Meeking D, Marchetti M, Russell-Jones DL, Anggard EE and Ritter JM. Oral treatment with antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with Type Il diabetes. Diabetologia 2000; 43:974-7.
32. Bursell S-E, Clermont AC, Aiello LP, Aielllo LM, Schlossman DK, Feener Eh EP. Laffel L and King GL. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type I diabetes. Diabetes Care 1999; 22:1245-51.
33. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ and Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17:189-212.
34. Low PA, Nickander KK and Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 1997; 46:S38-42.
35. Lal MA, Korner A, Matsuo Y, Zelenin S, Cheng SX, Jaremko G, DiBona GF, Eklof AC and Aperia A. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 2000; 49:1381-9.
36. 2-isoprostanes mediate high glucose-induced TGF-β synthesis and glomerular proteinuria in experimental type I diabetes. Kidney International 2000; 58:1963-72.
37. Halliwell B. Antioxidant defence mechanisms: From the beginning to the end (of the beginning). Free Rad Res 1999; 31:261-72.
38. Knekt P, Reunanen A, Marniemi J, Leino A and Aromaa A. Low vitamin E status is a potential risk factor for insulin-dependent diabetes mellitus. J Intern Med 1999; 245:99-102.
39. Salonen JT, Nyyssonen K, Tuomainen TP, Maenpaa PH, Korpela H, Kaplan GA, Lynch J, Helmrich SP and Salonen R. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: A four year follow up study in men. BMJ 1995; 311:1124-7.
40. Ford ES. Vitamin supplement use and diabetes mellitus incidence among adults in the United States. Am J Epidemiol 2001; 153:892-7.
41. Halliwell B. The antioxidant paradox. Lancet 2000; 355:1179-80.
42. Gopaul NK, Manraj MD, Hébé A, Yan SLK, Johnston A, Carrier MJ, Anggard EE. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 2001; 44:706-12.
43. Facchini FS, Humphreys MH, DoNascimento CA, Abbasi F and Reaven GM. Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols. Am J Clin Nutr 2000; 72:776-9.
44. Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: How should we move forward? Cardiovasc Res 2000; 47:410-8.
45. Sun F, Iwaguchi K, Shudo R, Nagaki Y, Tanaka K, Ikeda K, Tokumaru S and Kojo S. Change in tissue coneentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes. Clin Sci 1999; 96:185-90.
46. Simán CM and Eriksson UJ. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 1997; 46:1054-61.
47. Love A, Cotter MA, Cameron NE. Effects of alpha-tocopherol on nerve conduction velocity and regeneration following a freeze lesion in immature diabetic rats. Arch Pharmacol 1997; 355:126-30.
48. Karasu C, Ozansoy G, Bozkurt O, Erdogan D and Omeroglu S. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism 1997; 46:872-9.
49. Slonim AE, Surber ML, Page DL, Sharp RA and Burr IM. Modification of chemically induced diabetes in rats by vitamin E. Supplementation minimizes and depletion enhances development of diabetes. J Clin Invest 1983; 71:1282-8.
50. 2-isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: Effects of vitamin E. Eur J Pharmacol 1999; 377:89-92.
51. Laight DW, Desari KM, Anggard EE and Carrier MJ. Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo. Eur J Pharmacol 2000; 402:95-99.
52. Ihara Y, Yamada Y, Toyokuni S, Miyawaki K, Ban N, Adachi T, Kuroe A, Iwakura T, Kubota A, Hiai H and Seino Y. Antioxidant α-tocopherol ameliorates glycemic control of GK rats, a model of type 2 diabetes. FEBS Letters 2000; 473:24-6.
53. Tanaka Y, Gleason CE, Tran POT, Harmon JS and Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 1999; 96:10857-62.
54. Tajiri Y and Grill VE. Interactions between vitamin E and glucose on B-cell functions in the rat: An in vivo and in vitro study. Pancreas 1999; 18:274-281
55. Pozzilli P, Visalli N, Cavollo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli MC, Crino A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Suppa M, Sulli N, De Mattia G, Faldetta MR and Suraci MT. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study). Eur J Endocrinol 1997; 137:234-9.
56. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, llanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343-50.
57. Fujimoto WY, Bergstrom RW, Boyko EJ, Chen KW, Kahn SE, Leonetti DL, McNeely MJ, Newell LL, Shofer JB, Tsunehara CH and Wahl PW. Preventing diabetes - Applying pathophysiological and epidemiological evidence. Br J Nutr 2000; 84:S173-6.
58. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG and Willett WC. Diet, lifestyle and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345:790-7.
59. Halliwell B. Establishing the significance and optimal intake of dietary antioxidants: The biomarker concept. Nutr Rev 1999; 57:104-13.
60. Vasankari T, Fogelholm M, Kukkonen-Harjula K, Nenonen A, Kujala U, Oja P, Vuori I, Pasanen P, Neuvonen K and Ahotupa M. Reduced oxidized low-density lipoprotein after weight reduction in obese premenopausal women. Int J Obes Relat Metab Disord 2001; 25:205-11.
61. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, Prabhala A, Afzal A and Garg R. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001; 86:355-62.
62. Strauss RS. Comparison of serum concentrations of alpha-tocopherol and beta-carotene in a cross-sectional sample of obese and nonobese children (NHANES III). National Health and Nutrition Examination Survey. J Pediatr 1999; 134:160-5.
63. Kuno T, Hozumi M, Morinobu T, Murata T, Mingei Z and Tamai H. Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls. Free Radic Res 1998; 28:81-6.
64. Goth L and Eaton JW. Hereditary catalase deficiencies and increased risk of diabetes. Lancet 2000; 356:1820-1.
65. Meagher EA, Barry OP, Lawson JA, Rokach J and FitzGerald GA. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 2001; 285:1178-82.
66. Devaraj S and Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Rad Biol Med 2000; 29:790-2.
67. Upritchard JE, Sutherland WHF and Mann JI. Effect of supplementation with tomato juice, vitamin E and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2000; 23:733-8.
68. Gazis A, White DJ, Page SR and Cockcroft JR. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med 1999; 16:304-11.
69. Skyrme-Jones RA, O'Brien RC, Berry KL and Meredith IT. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: A randomized, placebo-controlled study. J Am Coll Cardiol 2000; 36:94-102.
70. Paolisso G, Tagliamonte MR, Barbieri M, Zito GA, Gambardella A, Varricchio G, Ragno E and Varricchio M. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. J Clin Endocrinol Metab 2000; 85:109-15.
71. Title LM, Cummings PM, Giddens K and Nassar BA. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: An effect prevented by vitamins C and E. J Am Coll Cardiol 2000; 36:2185-91.
72. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M and D'Onofrio F. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993; 57:650-4.
73. Paolisso G, D'Amore A, Galzerano D, Balbi V, Giugliano D, Varricchio M and D'Onofrio F. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993; 16:1433-7.
74. Manzella D, Barbieri M, Fagno E, Paolisso G. Chronic administration of pharmacologic doses of vitamin E improves cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr 2001; 73:1052-7.
75. Tutuncu NB, Bayraktar M and Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: A preliminary study. Diabetes Care 1998; 21:1915-8.
76. Skrha J, Sindelka G, Kvasnika J, Hilgertova J. Insulin action and fibrinolysis influenced by vitamin E in obese Type 2 diabetes mellitus. Diabetes Res Clin Pract 1999; 44:27-33.
77. Skrha J, Sindelka G and Hilgertova J. The effect of fasting and vitamin E on insulin action in obese type 2 diabetes mellitus. Ann NY Acad Sci 1997; 20:556-60.
78. Ferber P, Moll K, Koschinsky T, Rosen P, Susanto F, Schwippert B and Tschope D. High dose supplementation of RRR-alpha-tocopherol decreases cellular hemostasis but accelerates plasmatic coagulation in type 2 diabetes mellitus. Horm Metab Res 1999; 31:665-71.
79. Gisinger C, Jeremy J, Speiser P, Mikhailidis D, Dandona P and Schernthaner G. Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Double-blind crossover trial. Diabetes 1988; 37:1260-4.
80. Jain KS, Krueger KS, McVie R, Jaramillo JJ, Palmer M and Smith T. Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type I diabetic patients. Diabetes Care 1998; 21:1511-5.
81. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 2001; 447-55.
82. Keith ME, Jeejeebhoy KN, Langer A, Kurian R, Barr A, O'Kelly B and Sole MJ. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001; 73:219-24
83. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M and Green MS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomized placebo-controlled trial. Lancet 2000; 356:1213-8.
84. Lonn EM, Yusuf S, Dzavik V, Doris CI, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley WA, Teo KK. Effects of ramipril and vitamin E on atherosclerosis. The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001; 103:919-25
85. Yusuf S, Dagenais G, Pogue J, Bosch J and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study. N Engl J Med 2000; 342:154-60.
86. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA and Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328:1450-6.
87. Kaikkonen, J. Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men. Free Rad Res. 2001; 35:967-8.
88. Salonen JT (2002). Clinical trials testing cardiovascular benefits of antioxidant supplementation. Free Rad. Res. In Press.